Bioactive Peptides as Pharmacological Tools and Novel Drug Leads. Bioactive peptides are produced by all organisms and play numerous critical physiological roles, including in cellular communication, host defence and capture of prey. Peptides have huge potential as tools for studying roles of signalling pathways and as novel drugs due to their high affinity and selectivity for various therapeutically relevant targets. However their use has been limited by poor in vivo stability. This project is ....Bioactive Peptides as Pharmacological Tools and Novel Drug Leads. Bioactive peptides are produced by all organisms and play numerous critical physiological roles, including in cellular communication, host defence and capture of prey. Peptides have huge potential as tools for studying roles of signalling pathways and as novel drugs due to their high affinity and selectivity for various therapeutically relevant targets. However their use has been limited by poor in vivo stability. This project is focused on studying structural features of a range of peptides and their contributions to both activity and to resistance against degradation, with the aim to develop stabilised bioactive peptide sequences for in vivo applications, allowing the full potential of peptides as drugs to be realised.Read moreRead less
Discovery Early Career Researcher Award - Grant ID: DE130101673
Funder
Australian Research Council
Funding Amount
$375,000.00
Summary
Access to biomimetic carbohydrate receptors using dynamic combinatorial chemistry. This project aims to utilise novel synthetic technology for the development of cyclic peptide libraries as novel drug leads for the treatment of Dengue virus, HIV and cancer.
Discovery Early Career Researcher Award - Grant ID: DE170100525
Funder
Australian Research Council
Funding Amount
$372,000.00
Summary
Mucus control: Applying concepts from bacteriophage-mucus interactions. This project aims to examine how mucus-adherent bacteriophage interact with bacteria in mucus as a mechanism to manipulate microbiomes. Bacterial infections at mucosal surfaces in animals are a serious global health threat. Traditionally antibiotics have been used to curb mucosal infections, but antibiotic resistance means new therapies are urgently needed. Bacteriophage – viruses that infect bacteria – can kill bacteria and ....Mucus control: Applying concepts from bacteriophage-mucus interactions. This project aims to examine how mucus-adherent bacteriophage interact with bacteria in mucus as a mechanism to manipulate microbiomes. Bacterial infections at mucosal surfaces in animals are a serious global health threat. Traditionally antibiotics have been used to curb mucosal infections, but antibiotic resistance means new therapies are urgently needed. Bacteriophage – viruses that infect bacteria – can kill bacteria and might provide a layer of antimicrobial immunity in animal mucus. The anticipated outcomes are resolving how bacteriophage control bacteria within mucus, and applying concepts to bioengineer mucosal microbiomes.Read moreRead less
Discovery Early Career Researcher Award - Grant ID: DE120101730
Funder
Australian Research Council
Funding Amount
$375,000.00
Summary
Targeting cell death pathways in parasites. Schistosomiasis is a disease caused by parasitic worms. Due to the potential for drug resistance, new drugs are needed. This project aims to identify the components needed for parasite survival based on a cell death pathway in schistosomes. Neutralising the activities of these proteins should cause parasite death, providing a new treatment strategy.
Structural and functional characterisation of compounds that inhibit the malarial aminopeptidases. Malaria is the world's most prevalent parasitic disease. Due to the rapid spread of drug resistant parasites there is a need to develop new antimalarial drugs. In this proposal we will characterise new targets and novel methods of inhibition that will form the basis of a new mechanism for antimalarial drugs.
Investigating the intercellular trafficking of proteins and RNA and its relevance to neurodegenerative diseases. Alzheimer's and prion diseases are neurodegenerative disorders associated with protein misfolding. This project brings together similar features of these diseases using novel cell- and animal-based studies to develop a greater understanding of the molecular basis of these disorders.